ID: ALA5204851

Max Phase: Preclinical

Molecular Formula: C20H26N4O4

Molecular Weight: 386.45

Representations

Canonical SMILES:  COC(=O)c1cc(O)c2cc(NC(=O)CCCCCCNC(=N)N)ccc2c1

Standard InChI:  InChI=1S/C20H26N4O4/c1-28-19(27)14-10-13-7-8-15(12-16(13)17(25)11-14)24-18(26)6-4-2-3-5-9-23-20(21)22/h7-8,10-12,25H,2-6,9H2,1H3,(H,24,26)(H4,21,22,23)

Standard InChI Key:  OYMMXDRXZNDYBB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 386.45

Molecular Weight (Monoisotopic): 386.1954

AlogP: 2.70

#Rotatable Bonds: 9

Polar Surface Area: 137.53

Molecular Species: BASE

HBA: 5

HBD: 5

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 6

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.69

CX Basic pKa: 12.19

CX LogP: 2.22

CX LogD: 0.99

Aromatic Rings: 2

Heavy Atoms: 28

QED Weighted: 0.19

Np Likeness Score: -0.24

References

1. Iannelli G, Milite C, Marechal N, Cura V, Bonnefond L, Troffer-Charlier N, Feoli A, Rescigno D, Wang Y, Cipriano A, Viviano M, Bedford MT, Cavarelli J, Castellano S, Sbardella G..  (2022)  Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach.,  65  (17.0): [PMID:35482954] [10.1021/acs.jmedchem.2c00252]

Source

Source(1):

• Scientific Literature